Viatris (VTRS) Short-Term Debt issuances (2020 - 2025)
Viatris (VTRS) posted quarterly Short-Term Debt issuances of -$1.5 million for Q4 2025, little changed year-over-year from -$1.5 million in Q4 2024, and down 600.0% quarter-over-quarter from $300000.0 in Q3 2025.
Viatris (VTRS) Short-Term Debt issuances (2020 - 2025) Analysis & Trends
Viatris' Short-Term Debt issuances history runs 6 years deep, the most recent figure standing at -$1.5 million for Q4 2025.
- In Q4 2025, Short-Term Debt issuances changed 0.0% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$1.2 million (down 185.71% YoY), while the FY2025 annual figure was $200000.0, changed N/A from the prior year.
- Short-Term Debt issuances for Q4 2025 stood at -$1.5 million, down from $300000.0 in the prior quarter.
- The five-year high for Short-Term Debt issuances was $1.3 billion in Q2 2021, with the low at -$1.1 billion in Q1 2021.
- The 5-year median for Short-Term Debt issuances is -$1.5 million (2024), against an average of -$64.7 million.
- The sharpest annual moves came in 2023 and 2024: Short-Term Debt issuances jumped 124.42% in 2023, then tumbled 1600.0% in 2024.
- Viatris' Short-Term Debt issuances stood at -$214.0 million in 2021, then slumped by 133.83% to -$500.4 million in 2022, then surged by 100.02% to $100000.0 in 2023, then sank by 1600.0% to -$1.5 million in 2024, then changed by 0.0% to -$1.5 million in 2025.
- Business Quant data shows VTRS's Short-Term Debt issuances at -$1.5 million in Q4 2025, $300000.0 in Q3 2025, and $1.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 50.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.50 Mn |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Dec 31, 2024 | -1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | -22.90 Mn |
| Sep 30, 2023 | -22.90 Mn |
| Jun 30, 2023 | -181.50 Mn |
| Jun 30, 2023 | -181.50 Mn |
| Mar 31, 2023 | 204.60 Mn |
| Mar 31, 2023 | 204.60 Mn |
| Dec 31, 2022 | -500.40 Mn |
| Dec 31, 2022 | -500.40 Mn |